MARKET

BFRI

BFRI

Biofrontera Inc
NASDAQ
0.9259
-0.0116
-1.24%
After Hours: 0.9399 +0.014 +1.51% 19:09 11/12 EST
OPEN
0.9375
PREV CLOSE
0.9375
HIGH
0.9400
LOW
0.9120
VOLUME
131.59K
TURNOVER
--
52 WEEK HIGH
1.660
52 WEEK LOW
0.5547
MARKET CAP
13.75M
P/E (TTM)
-1.5776
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BFRI last week (1102-1106)?
Weekly Report · 3d ago
Weekly Report: what happened at BFRI last week (1026-1030)?
Weekly Report · 11/02 10:25
Weekly Report: what happened at BFRI last week (1019-1023)?
Weekly Report · 10/26 10:25
Weekly Report: what happened at BFRI last week (1012-1016)?
Weekly Report · 10/19 10:25
Weekly Report: what happened at BFRI last week (1005-1009)?
Weekly Report · 10/12 10:31
Biofrontera Submits Ameluz SNDA For Expanded Actinic Keratosis Use
NASDAQ · 10/08 13:47
Biofrontera submits sNDA to FDA to expand Ameluz indication
TipRanks · 10/08 13:37
Biofrontera Refiles Supplemental New Drug Application For Ameluz Topical Gel To FDA To Treat Actinic Keratoses
Benzinga · 10/08 13:24
More
About BFRI
Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Webull offers Biofrontera Inc stock information, including NASDAQ: BFRI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRI stock methods without spending real money on the virtual paper trading platform.